HomeOpen Access NewsClinical Trials

Clinical Trials

MHRA approves Tofersen for rare inherited form of motor neurone disease

The MHRA has approved Tofersen to treat SOD1-related motor neurone disease (MND), a rare inherited form of the condition.

Fostering and supporting excellence in clinical pharmacy practice

Islam Elkonaissi and Zahra Laftah from the UKCPA explore the British model of supporting excellence in clinical pharmacy practice In the UK, evidence that pharmacists...

Early stage diagnosis – spotting early stage cancer events

Cecilia Van Cauwenberghe, Vandana Iyer and Bhargav Rajan from Frost & Sullivan examine of how nanotechnology helps spot early stage cancer

Dose-finding trials: why not to use algorithmic designs

Prof Thomas Jaki from the Medical and Pharmaceutical Statistics Research Unit at Lancaster University sheds light on dose-finding trials

From biobanking to precision medicine

A group of experts from ISBER shed light on the science of biobanking and its role in delivering modern and precision medicine

Treatments and symptoms of Parkinson’s

Prof. David Dexter, deputy director of research at Parkinson’s UK shares his thoughts on the symptoms of Parkinson’s and the chances of finding a cure

Publishing national chemotherapy data

Publishing national chemotherapy data has helped NHS hospitals make changes that should improve treatment, as Emma Saxon reveals in this article

Tumour-host interactions, paediatric sarcomas, and cancer progression

Ivan Stamenkovic, professor of experimental pathology at the University of Lausanne underlines research taking place around cancer progression Cancer progression, meaning the evolution of localised...

Chemical biology: A chance conversation but an important question

Research professor Prof Colin J Suckling OBE DSc FRSE discusses his engagement with medicinal chemistry and chemical biology

What is the future for clinical and health research in Europe?

Experts discuss the FEAM-BioMed Alliance paper, which outlines how the next EU Framework Programme can further support biomedical research in Europe

New biomarkers of lung injury in ARDS

Associate professor at CHU Clermont-Ferrand, Université Clermont Auvergne, Matthieu Jabaudon highlights the hopeful future for ARDS

Tissue-scale factors in predicting cancer treatment outcome

Zhihui Wang and Vittorio Cristini provide evidence that could improve the success of treatment plans and make predicting cancer treatment outcome easier Current processes for...

Cancer research and training take centre stage in NCI’s work

Open Access Government spoke to the National Cancer Institute’s Dr S Percy Ivy about cancer research and training and the importance of clinical trials The...

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders